Looking towards a FRESH future in 3D bioprinting

RAPID

Share this Article

FluidForm’s Adam Feinberg will be speaking at 3DPrint.com’s upcoming AMS online industry summit (Feb 9-10, 2021). Register here.

On January 16th, 2021, President Joe Biden introduced his science team for the incoming administration and made it clear that science and technology will see growing investment over the next 4 years. Even more exciting was Biden’s statement to imagine a future with “3-D printers restoring tissue after traumatic injuries and hospitals printing organs for organ transplant.”

It seems that this may finally be the decade that 3-D bioprinting moves from the realm of science fiction to a widely available clinical reality. Indeed, the past 5 years has seen major research advances in 3-D bioprinting that include perfusable vascular-like networks for rapidly building tissues, functional pieces of organs such as breathing lung alveoli and beating heart chambers, implantable scaffolds for repair of the spinal cord and the musculoskeletal system, and even full-size human heart scaffolds. However, it is important that the industry remains clear-eyed about the challenges that stand between where we are today, and the future that we are all striving to achieve.

It has been over 30 years since the field of tissue engineering first promised the ability to build replacement tissues, and nearly a decade since Organovo emerged as the first public company promising that 3-D bioprinting is the technology to make it happen. But the reality has been harsh. Today there are essentially no tissue engineered medical products on the market. The question many of us in the field have is whether now is the time that industry and the federal government will make the large-scale investments necessary to make good on the vision of 3-D bioprinted tissues and organs.

At FluidForm we believe the answer is yes, and that science will lead the way. More specifically, that we need to develop not just better printers and materials, but a deep understanding of how living cells interact with the scaffolds we build to develop instructive environments that speak the language of biology. Built on a technology known as Freeform Reversible Embedding of Suspended Hydrogels (FRESH™) printing licensed from Carnegie Mellon University, FRESH™ leverages a unique gel-like environment within which we can 3-D bioprint the widest combination of cells, bioinks, and biomaterials possible in nearly any direction to match properties of living tissue.

As a starting point, one can look at the human body and the way tissues and organs are created for inspiration. By dry weight, each of us is more collagen than anything else. In fact, collagen is the primary extracellular matrix (ECM) protein of nearly every tissue and organ in the body, making it one of the most exciting biomaterials to use in 3-D bioprinting. In 2019 our team published an improved version of FRESH™ printing in Science demonstrating that not only can native collagen be printed with high resolution, but that we can use this to create functional parts of the human heart. Importantly, the impact of using collagen for biofabrication is its ubiquity, enabling FluidForm to build tissue scaffolds for bone, cartilage, connective tissue, and many other applications.

Looking forward, we see FRESH™ 3-D bioprinting as a foundational technology, not because of what we have achieved to date, but because of what we see being built with FRESH™ in the future. As noted, it is going to take rigorous science to drive us towards realizing the vision of 3-D bioprinted organs that President Biden has brought to national attention. This is a primary reason that FluidForm’s first commercial product is LifeSupport™, a version of the FRESH™ support gel that we have made available through major partners to enable academic and industrial researchers to do innovative science and develop new high-impact applications. To that end, our internal development projects are focused on accelerating translation forward to the clinic and include medical devices, regenerative scaffolds for soft tissue repairs, biopharma models, and a 1st generation of 3-D bioprinted organs.

Share this Article


Recent News

3D Printing Webinar and Event Roundup: May 26, 2024

3D Printing News Briefs, May 25, 2024: 3D Printed Medical Models, Sensors, Engines, & More



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

Immensa and Pelagus 3D Collaborate to Tap “$2 Billion” 3D Printing Opportunity

Dubai’s Immensa, which claims to be the “largest digital manufacturer” in the Middle East/North Africa (MENA) region, has formed a strategic collaboration with Pelagus 3D, a Singapore-based, on-demand digital manufacturing...

US Army Contracts 3YOURMIND & Phillips Corp. for 3D Printed Tank Parts Identification

The US Army Combat Capabilities Development Command (DEVCOM) Ground Vehicle Systems Center (GVSC) has awarded 3YOURMIND and Phillips Corporation Federal Division a contract to develop part identification solutions for tanks....

Sponsored

Manufacturing World Tokyo 2024 Set to Showcase Innovation in AM, 3D Printing and More!

After the success of its Nagoya leg last April, Manufacturing World Tokyo 2024, one of Asia’s premier manufacturing exhibitions, is gearing up for its second leg this year, returning to...

3D Printing Webinar and Event Roundup: May 19, 2024

This week, Stratasys continues its advanced training and starts its Experience Stratasys tour across the United States. ASTM’s AMCOE continues its professional certificate course, and SPE is offering a workshop...